175 related articles for article (PubMed ID: 1717962)
1. Immunohistochemical studies of chromogranins (A and C) in pituitary adenomas.
Oda K; Inada K; Osamura RY
Pathol Res Pract; 1991 Jun; 187(5):626-8. PubMed ID: 1717962
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenomas. An immunohistochemical study of hormone production and chromogranin localization.
DeStephano DB; Lloyd RV; Pike AM; Wilson BS
Am J Pathol; 1984 Sep; 116(3):464-72. PubMed ID: 6089568
[TBL] [Abstract][Full Text] [Related]
3. Different expression of chromogranin A and chromogranin B in various types of pituitary adenomas.
Riva C; Leutner M; Capella C; Usellini L; la Rosa S; Brianza MR; Buffa R
Zentralbl Pathol; 1993 Jun; 139(2):165-70. PubMed ID: 8396420
[TBL] [Abstract][Full Text] [Related]
4. Gonadotropin-releasing hormone regulates gonadotropin beta-subunit and chromogranin-B messenger ribonucleic acids in cultured chromogranin-A-positive pituitary adenomas.
Song JY; Jin L; Chandler WF; England BG; Smart JB; Landefeld TD; Lloyd RV
J Clin Endocrinol Metab; 1990 Sep; 71(3):622-30. PubMed ID: 2118538
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analyses of oncocytic and chromophobe pituitary adenomas.
Günzl HJ; Saeger W; Diehl S; Lüdecke DK
Exp Clin Endocrinol; 1988 Sep; 92(1):51-8. PubMed ID: 2465910
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas.
Lloyd RV; Wilson BS; Kovacs K; Ryan N
Arch Pathol Lab Med; 1985 Jun; 109(6):515-7. PubMed ID: 2986572
[TBL] [Abstract][Full Text] [Related]
7. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
[TBL] [Abstract][Full Text] [Related]
8. Analysis of pituitary hormones and chromogranin A mRNAs in null cell adenomas, oncocytomas, and gonadotroph adenomas by in situ hybridization.
Lloyd RV; Jin L; Fields K; Chandler WF; Horvath E; Stefaneanu L; Kovacs K
Am J Pathol; 1991 Sep; 139(3):553-64. PubMed ID: 1653518
[TBL] [Abstract][Full Text] [Related]
9. Effects of somatostatin-14 and the receptor-specific somatostatin analogs on chromogranin A and alpha-subunit (alpha-SU) release from "clinically nonfunctioning" pituitary adenoma cells incubated in vitro.
Pawlikowski M; Lawnicka H; Pisarek H; Kunert-Radek J; Radek M; Culler MD
J Physiol Pharmacol; 2007 Mar; 58(1):179-88. PubMed ID: 17440235
[TBL] [Abstract][Full Text] [Related]
10. Chromogranin A and B in adenomas of the pituitary. An immunohistochemical study of 42 cases.
Schmid KW; Kröll M; Hittmair A; Maier H; Tötsch M; Gasser R; Finkenstett G; Hogue-Angeletti R; Fischer-Colbrie R
Am J Surg Pathol; 1991 Nov; 15(11):1072-7. PubMed ID: 1928557
[TBL] [Abstract][Full Text] [Related]
11. [Immunohistochemistry for pituitary hormones and Ki-67 in growth hormone producing pituitary adenomas].
Brito J; Sáez L; Lemp M; Liberman C; Michelsen H; Araya AV
Rev Med Chil; 2008 Jul; 136(7):831-6. PubMed ID: 18949157
[TBL] [Abstract][Full Text] [Related]
12. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of human natural killer cell like immunoreactivity in human pituitary adenomas, using monoclonal antibody NK-1.
Sanno N; Itoh J; Teramoto A; Itoh Y; Hori S; Osamura RY
J Neurooncol; 1997 Oct; 35(1):29-38. PubMed ID: 9266438
[TBL] [Abstract][Full Text] [Related]
14. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line.
Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY
Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of neuroendocrine secretory protein-55 (NESP-55) in pituitary adenomas.
Gupta M; Lloyd RV; Fischer-Colbrie R; Tischler AS; Dayal Y
Endocr Pathol; 2011 Sep; 22(3):150-4. PubMed ID: 21584660
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical analysis of GH-producing adenomas--with special emphasis on plurihormonality of individual tumor cells by double staining.
Inada K; Oda K; Utsunomiya H; Itoh J; Osamura RY
Tokai J Exp Clin Med; 1992 Dec; 17(5-6):213-22. PubMed ID: 1285309
[TBL] [Abstract][Full Text] [Related]
17. [Immunohistochemical and clinicoendocrinological studies of gonadotropin producing pituitary adenomas].
Sanno N; Teramoto A; Inada K; Osamura Y
No To Shinkei; 1992 Aug; 44(8):745-53. PubMed ID: 1419353
[TBL] [Abstract][Full Text] [Related]
18. Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas.
Ikuyama S; Mu YM; Ohe K; Nakagaki H; Fukushima T; Takayanagi R; Nawata H
Clin Endocrinol (Oxf); 1998 May; 48(5):647-54. PubMed ID: 9666878
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical expression of retinoid X receptor isoforms in human pituitaries and pituitary adenomas.
Sanno N; Sugawara A; Teramoto A; Abe Y; Yen PM; Chin WW; Osamura RY
Neuroendocrinology; 1997 Apr; 65(4):299-306. PubMed ID: 9143002
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of human pituitary adenomas determines the pattern of chromogranin/secretogranin messenger ribonucleic acid expression.
Jin L; Chandler WF; Smart JB; England BG; Lloyd RV
J Clin Endocrinol Metab; 1993 Mar; 76(3):728-35. PubMed ID: 7680355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]